Get started

Wedgebreakout

Unilever (ULVR.l) bearish scenario:The technical figure Rising Wedge can be found in the daily chart in the UK company Unilever PLC (ULVR.l). Unilever plc is a British multinational consumer goods company. Unilever products include food, condiments, ice cream, cleaning agents, beauty products, and personal care. Unilever is the largest producer of soap in the world, and its products are available in around 190 countries. The Rising Wedge broke through the support line on 04/10/2022. If the price holds below this level, you can have a possible bearish price movement with a forecast for the next 31 days towards 3 647.00 GBp. Your stop-loss order, according to experts, should be placed at 4 178.00 GBp if you decide to enter this position. In the first half of 2022, Unilever's growth accelerated again as its robust sales in the U.S., India, and other markets easily offset its lockdown-induced disruptions in China. It also raised its prices to offset the impact of inflation. For the full year, it expects underlying sales to grow by more than 6.5%. Unilever's underlying earnings per share (EPS) rose 5.5% in 2021, but grew just 1% year-over-year in the first half of 2022 as the inflation and currency headwinds squeezed its margins. It expects its underlying operating margin to decline about 240 basis points to 16% this year. Risk Disclosure: Trading Foreign Exchange (Forex) and Contracts of Difference (CFD's) carries a high level of risk. By registering and signing up, any client affirms their understanding of their own personal accountability for all transactions performed within their account and recognizes the risks associated with trading on such markets and on such sites. Furthermore, one understands that the company carries zero influence over transactions, markets, and trading signals, therefore, cannot be held liable nor guarantee any profits or losses.
LSE:ULVRShort
by legacyFXofficial
AbbVie. Waiting for an exit from uptrendAbbVie Inc. Idea: Long Horizon: 1-2 months Target: $145 Entry range: $143-145 Stop order: $141 Technical analysis The share price has formed a short-term uptrend. If the local resistance level is broken through, there is a potential to move higher. Idea to increase the stock with the target of $145. Fundamental factor AbbVie is an American biopharmaceutical company founded in 2013 by a spinoff from Abbott Laboratories. One of the largest pharmaceutical companies in the world. Healthcare is a classic defensive sector in times of stock market turbulence. Given the high likelihood of continued serious tightening of monetary policy by the Fed, investors are shifting funds from interest-rate-dependent sectors to more stable ones. AbbVie's broadly diversified portfolio of drugs and products makes it one of the best candidates for this strategy.
NYSE:ABBVLong
by SiriusBH
US OIL SHORTFrom the W1 timeframe, we can see a double top pattern that successfully broken the neckline confirming bearish pressure. Also, last weeks WI candle closed bearish confirming sell momentum. On the D1, we can clearly see that price pulled back after what looked like a head and shoulders pattern and after failing to break the neckline slumped back below support. This also indicates strong bearish momentum. Finally on my entry timeframe the H4, we see the ascending wedge which broke and came back to support to resistance before heading lower.
TVC:USOILShort
by Dak_Trader